Noticias de PFE_US
Noticias del mercado
Últimas noticias sobre PFE_US — 665 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Pfizer (NYSE:PFE) Chairman and Chief Executive Officer Albert Bourla said the drugmaker has addressed several major headwinds that weighed on investor attention, including policy uncertainty, declining COVID-19-related demand and upcoming losses of exclusivity for certain products. Speaking at a Mo
Pfizer stock closed at USD 27.69 on the NYSE on September 11, 2026, modestly above consensus price t
At the close on September 11, 2026, Pfizer stock ended slightly higher on the NYSE, with the move co
A -988.31% payout ratio sounds like disaster, but Pfizer’s CEO just vowed the dividend survives even the most stretched scenario management can run.
Pfizer develops medicines and vaccines across several therapeutic areas. The reference base is the X
At the close on September 10, 2026, Pfizer stock finished near USD 27.50 on the NYSE with roughly a
If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.
Pfizer Inc. stock closed at USD 27.79 on the NYSE on September 9, 2026, 2.32% below the prior sessio
Novartis India Share Price: Novartis India acquired the Minipress and Minipres trademarks in India and certain related intellectual property rights from Pfizer Inc and Pfizer Products Inc for ₹1,250 crore.
At the close on September 9, 2026, Pfizer stock finished at USD 27.79 on the NYSE after falling 2.3
On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & Johnson (NYSE:JNJ) or Cardinal Health (NYSE:CAH). Mad Money host Jim Cramer said: Well, I’ll tell you… I think it’s always good to look at Lilly as a stock […]
The two companies had announced on Monday that NIL had inked an agreement with Pfizer Inc to acquire the trademarks for India, besides certain related intellectual property rights, for ₹1,250 crore
Pfizer Inc. stock closed at USD 27.79 on September 8, 2026 on the NYSE, around 11.6 percent above it
Página 27 de 34